Research Article
Pleiotropic Properties of Valsartan: Do They Result from the Antiglycooxidant Activity? Literature Review and In Vitro Study
Table 3
The effects of valsartan, Trolox, NAC, ALA, captopril, aminoguanidine, or metformin addition to BSA + ribose solution on protein oxidation, glycooxidation, and antioxidant activity.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Abbreviations: AGE: advanced glycation end products; ALA: alpha-lipoic acid; AOPP: advanced oxidation protein products; BSA: bovine serum albumin; DPPH: 2,2-di-phenyl-1-picrylhydrazyl radical scavenging capacity; FRAP: ferric reducing antioxidant power; NAC: N-acetylcysteine; PC: protein carbonyls; Rib: ribose; TAC: total antioxidant capacity; vs. control; vs. control; vs. control; vs. control. |